Search - tctmd.com

Displaying 1 - 20 of 60

Sort: Relevancy | Date

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

News Daily News

CVD Still the Leading Cause of Death and Disease Globally

Michael O'Riordan

September 24, 2025

News Daily News

Wider Use of Polypills to Prevent CVD Could Save Millions of Lives by 2050

Todd Neale

July 16, 2025

News Daily News

Use of Secondary CVD Prevention Meds Still Meager Worldwide

Caitlin E. Cox

February 03, 2025

News Conference News TCT 2024

In STEMI, Giving Heparin Pre-Cath Lab May Boost Reperfusion: HELP-PCI

Yael L. Maxwell

October 29, 2024

News Daily News

Aligning Pill Burden and Palliative Care Needs in Late-Stage CVD: AHA

L.A. McKeown

July 02, 2024

News Daily News

Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years

Yael L. Maxwell

June 26, 2024

News Daily News

As Trends Reverse in CVD, AHA Warns of Soaring Costs and Illness

L.A. McKeown

June 05, 2024

News Conference News ACC 2024

Need a Statin for Primary Prevention? There’s an App for That

Michael O'Riordan

April 10, 2024

News Daily News

Mortality Risk Varies Among Patients With Very High LDL Levels

Michael O'Riordan

November 17, 2023

News Conference News TCT 2023

Does Thrombolysis Have a Role in a Primary-PCI World? Experts Hash It Out

Michael O'Riordan

October 25, 2023

News Daily News

Prescribing a Generic for CVD? Plan, Drug Type, and Condition Impact Availability

Todd Neale

September 13, 2023

News Daily News

Statin Therapy Still Lacking for Many US Patients With ASCVD

L.A. McKeown

August 07, 2023

News CV Team Pro

Viet Le

L.A. McKeown

July 07, 2023

News Opinion CV Team Dispatch

January 2023 News Roundup

L.A. McKeown

January 16, 2023

News Daily News

Sustained LDL-Cholesterol Reductions With Inclisiran: ORION-3

Michael O'Riordan

January 16, 2023

News Daily News

Top Coronary Artery Disease News of 2022

Yael L. Maxwell

December 29, 2022

News Daily News

Many STEMI Patients Not Treated Within National Time Goals

Michael O'Riordan

November 15, 2022

News Conference News AHA 2022

BRIGHT-4: Large, ‘Clean’ Trial Clarifies Bivalirudin Benefits in STEMI

Shelley Wood

November 06, 2022

News Conference News TCT 2022

New Faces, New Formats, New Tech: What to Expect From TCT 2022

Shelley Wood

September 07, 2022

Advertisement

What’s Going to Be Hot at TCT 2025

CVD Still the Leading Cause of Death and Disease Globally

Wider Use of Polypills to Prevent CVD Could Save Millions of Lives by 2050

Use of Secondary CVD Prevention Meds Still Meager Worldwide

In STEMI, Giving Heparin Pre-Cath Lab May Boost Reperfusion: HELP-PCI

Aligning Pill Burden and Palliative Care Needs in Late-Stage CVD: AHA

Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years

As Trends Reverse in CVD, AHA Warns of Soaring Costs and Illness

Need a Statin for Primary Prevention? There’s an App for That

Mortality Risk Varies Among Patients With Very High LDL Levels

Does Thrombolysis Have a Role in a Primary-PCI World? Experts Hash It Out

Prescribing a Generic for CVD? Plan, Drug Type, and Condition Impact Availability

Statin Therapy Still Lacking for Many US Patients With ASCVD

Viet Le

January 2023 News Roundup

Sustained LDL-Cholesterol Reductions With Inclisiran: ORION-3

Top Coronary Artery Disease News of 2022

Many STEMI Patients Not Treated Within National Time Goals

BRIGHT-4: Large, ‘Clean’ Trial Clarifies Bivalirudin Benefits in STEMI

New Faces, New Formats, New Tech: What to Expect From TCT 2022

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content